المؤلفون: Sepe P., Martinetti A., Mennitto A., Verzoni E., Claps M., Raimondi A., Sottotetti E., Grassi P., Guadalupi V., Stellato M., Zattarin E., Di Maio M., Procopio G.

المساهمون: Sepe P., Martinetti A., Mennitto A., Verzoni E., Claps M., Raimondi A., Sottotetti E., Grassi P., Guadalupi V., Stellato M., Zattarin E., Di Maio M., Procopio G.

مصطلحات موضوعية: circulating angiogenic factor, circulating biomarker, pazopanib, renal cell carcinoma, TKI, Aged, Angiogenesis Inhibitor, Antineoplastic Agent, Carcinoma, Renal Cell, Chemokine CXCL12, Disease Progression, E-Selectin, Female, Hepatocyte Growth Factor, Human, Interleukin-6, Interleukin-8, Kidney Neoplasm, Male, Middle Aged, Osteopontin, Progression-Free Survival, Prospective Studie, Pyrimidine, Response Evaluation Criteria in Solid Tumor, Sulfonamide, Survival Rate, Translational Medical Research, Vascular Endothelial Growth Factor A

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32889831; info:eu-repo/semantics/altIdentifier/wos/WOS:000570127200003; volume:43; issue:9; firstpage:621; lastpage:627; numberofpages:7; journal:AMERICAN JOURNAL OF CLINICAL ONCOLOGY: CANCER CLINICAL TRIALS; http://hdl.handle.net/2318/1770062Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85085770569

الإتاحة: https://doi.org/10.1097/COC.0000000000000719Test
http://hdl.handle.net/2318/1770062Test

المؤلفون: Tommasi, Chiara, Scartabellati, Giulia, Giannarelli, Diana, Giorgi, Ugo De, Brighi, Nicole, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Buti, Sebastiano

المساهمون: Tommasi, Chiara, Scartabellati, Giulia, Giannarelli, Diana, Giorgi, Ugo De, Brighi, Nicole, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Buti, Sebastiano

مصطلحات موضوعية: anisocytosi, cabozantinib, macrocytosi, metastatic renal cell carcinoma, pazopanib, prognostic

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37492625; info:eu-repo/semantics/altIdentifier/wos/WOS:001156531500001; volume:15; firstpage:1; lastpage:24; numberofpages:24; journal:THERAPEUTIC ADVANCES IN UROLOGY; https://hdl.handle.net/11562/1100728Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85165597211

الإتاحة: https://doi.org/10.1177/17562872231187216Test
https://hdl.handle.net/11562/1100728Test

المؤلفون: Corianò, Matilde, Giannarelli, Diana, Scartabellati, Giulia, De Giorgi, Ugo, Brighi, Nicole, Fornarini, Giuseppe, Tommasi, Chiara, Giudice, Giulia Claire, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Signori, Alessio, Banna, Giuseppe Luigi, Buti, Sebastiano

المساهمون: Corianò, Matilde, Giannarelli, Diana, Scartabellati, Giulia, De Giorgi, Ugo, Brighi, Nicole, Fornarini, Giuseppe, Tommasi, Chiara, Giudice, Giulia Claire, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Signori, Alessio, Banna, Giuseppe Luigi, Buti, Sebastiano

مصطلحات موضوعية: Cabozantinib, dose reduction, metastatic renal cell carcinoma (mRCC), pazopanib, prognostic, schedule modification, tailoring, temporary interruption

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37017710; info:eu-repo/semantics/altIdentifier/wos/WOS:000969081500001; volume:23; issue:5; firstpage:545; lastpage:554; numberofpages:10; journal:EXPERT REVIEW OF ANTICANCER THERAPY; https://hdl.handle.net/11562/1091289Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85152379398

الإتاحة: https://doi.org/10.1080/14737140.2023.2200168Test
https://hdl.handle.net/11562/1091289Test

المؤلفون: Matilde Corianò, Diana Giannarelli, Giulia Scartabellati, Ugo De Giorgi, Nicole Brighi, Giuseppe Fornarini, Chiara Tommasi, Giulia Claire Giudice, Sara Elena Rebuzzi, Silvia Puglisi, Orazio Caffo, Stefania Kinspergher, Alessia Mennitto, Carlo Cattrini, Matteo Santoni, Elena Verzoni, Alessandro Rametta, Marco Stellato, Andrea Malgeri, Giandomenico Roviello, Matteo Brunelli, Alessio Signori, Giuseppe Luigi Banna, Sebastiano Buti

مصطلحات موضوعية: temporary interruption, Oncology, dose reduction, metastatic renal cell carcinoma (mRCC), tailoring, pazopanib, Pharmacology (medical), Cabozantinib, prognostic, schedule modification

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::201fdce06eaf7cf75b4f509952bcdce0Test
https://hdl.handle.net/11562/1091289Test

المؤلفون: Massimo Di Maio, Marco Stellato, Alessia Mennitto, Elena Verzoni, Paolo Grassi, Valentina Guadalupi, Elisa Sottotetti, Alessandra Raimondi, Giuseppe Procopio, Melanie Claps, Pierangela Sepe, Emma Zattarin, Antonia Martinetti

المصدر: American Journal of Clinical Oncology. 43:621-627

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, Oncology, Cancer Research, circulating angiogenic factors, Drug Resistance, Angiogenesis Inhibitors, Translational Research, Biomedical, 0302 clinical medicine, Renal cell carcinoma, pazopanib, Prospective Studies, 030212 general & internal medicine, Osteopontin, Prospective cohort study, Translational Medical Research, Sulfonamides, biology, Hepatocyte Growth Factor, circulating biomarkers, Middle Aged, TKI, Kidney Neoplasms, Progression-Free Survival, Survival Rate, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Disease Progression, Female, E-Selectin, medicine.drug, renal cell carcinoma, medicine.medical_specialty, Indazoles, Antineoplastic Agents, Aged, Carcinoma, Renal Cell, Chemokine CXCL12, Humans, Interleukin-6, Interleukin-8, Pyrimidines, Drug Resistance, Neoplasm, Pazopanib, 03 medical and health sciences, Internal medicine, Carcinoma, medicine, Progression-free survival, Survival rate, business.industry, Renal Cell, medicine.disease, biology.protein, Neoplasm, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0893db53ea30508768aa8057e6975a1aTest
https://doi.org/10.1097/coc.0000000000000719Test

المؤلفون: Elena Verzoni, Giuseppina Calareso, Paolo Grassi, Michele Prisciandaro, Filippo de Braud, Raffaele Ratta, Luca Porcu, Giuseppe Procopio, Alessia Mennitto

المصدر: Drugs in R&D

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Indazoles, Urology, Angiogenesis Inhibitors, Disease-Free Survival, Pazopanib, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Humans, Original Research Article, Neoplasm Metastasis, Carcinoma, Renal Cell, Dose Modification, Proportional Hazards Models, Retrospective Studies, Pharmacology, Sulfonamides, Performance status, Dose-Response Relationship, Drug, business.industry, Standard treatment, Hazard ratio, Middle Aged, medicine.disease, Kidney Neoplasms, Discontinuation, 030104 developmental biology, Pyrimidines, Treatment Outcome, 030220 oncology & carcinogenesis, Toxicity, Female, business, Progressive disease, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b2b90e3123393a4a7f62d5d66dde2Test
http://europepmc.org/articles/PMC5629143Test

المؤلفون: G. Procopio, Giovanni Fucà, Elena Verzoni, P Luca, Raffaele Ratta, Alessia Mennitto, Paolo Grassi, A. Martinetti

المصدر: Annals of Oncology. 28:vi20

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, First line, Hematology, Affect (psychology), medicine.disease, Pazopanib, Renal cell carcinoma, Internal medicine, medicine, business, medicine.drug, Dose Modification

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7b98475d3e831c29f282cc9bc5ecf782Test
https://doi.org/10.1093/annonc/mdx423.010Test

المؤلفون: Alessia Mennitto, Luca Porcu, Giuseppe Procopio, Elena Verzoni, Antonia Martinetti, Raffaele Ratta, Paolo Grassi

المصدر: Journal of Clinical Oncology. 35:512-512

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, business.industry, Standard treatment, Urology, ECOG Performance Status, medicine.disease, Discontinuation, Pazopanib, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Oncology, Renal cell carcinoma, 030220 oncology & carcinogenesis, Toxicity, Medicine, business, Dose Reduced, Dose Modification, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::51a3e3cd736605045c69d03576873304Test
https://doi.org/10.1200/jco.2017.35.6_suppl.512Test